benzoin sumatra + storax: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
benzoin sumatra + storax: clinical details
Prescribing considerations
- The selected eMC product is marked discontinued; verify the exact preparation and current availability.
- External use only. Account for ethanol content, flammability and accidental-ingestion risk.
- For inhalation, balance limited symptomatic intent against the scald risk from hot water.
- The inhalation route is unsuitable for infants under 3 months.
Contraindications and cautions
- Known hypersensitivity to Sumatra benzoin or storax.
- Do not use as an inhalant in children under 3 months.
Monitoring
- No routine laboratory monitoring is described.
- Review persistent or worsening symptoms.
- Monitor exposed skin for irritation or allergic contact dermatitis and stop treatment if these occur.
Clinical pharmacology
Sumatra benzoin has aromatic inhalant, mild antiseptic and protective properties; storax contributes mild antiseptic activity. Pharmacokinetic information is unavailable.
Formulation and product differences
- The selected product is a dark-brown, ethanol-containing tincture with aloes and purified water, supplied in a glass bottle.
- No other selected formulation is represented on this page.
benzoin sumatra + storax interactions
No interactions with other medicines are known for the licensed external routes.
Sources
These sources were used to prepare and review this medicine page.
iatroX CPD
Keep a note for CPD
Save a private reflection with this source attached. Your first is free.
Record learning (opens in a new tab)Prepared and reviewed by the iatroX editorial team.